Deep learning with diffusion basis spectrum imaging for classification of multiple sclerosis lesions by Ye, Zezhong et al.
Washington University School of Medicine 
Digital Commons@Becker 
Open Access Publications 
5-1-2020 
Deep learning with diffusion basis spectrum imaging for 
classification of multiple sclerosis lesions 
Zezhong Ye 
Ajit George 
Anthony T Wu 
Xuan Niu 
Joshua Lin 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs 
Authors 
Zezhong Ye, Ajit George, Anthony T Wu, Xuan Niu, Joshua Lin, Gautam Adusumilli, Robert T Naismith, 
Anne H Cross, Peng Sun, and Sheng-Kwei Song 
RESEARCH ARTICLE
Deep learning with diffusion basis spectrum imaging for
classification of multiple sclerosis lesions
Zezhong Ye1 , Ajit George1, Anthony T. Wu2, Xuan Niu1, Joshua Lin3, Gautam Adusumilli4,
Robert T. Naismith4, Anne H. Cross4 , Peng Sun1 & Sheng-Kwei Song1
1Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, 63110
2Department of Biomedical Engineering, Washington University, St. Louis, Missouri, 63130
3Keck School of Medicine, University of Southern California, Los Angeles, California, 90033
4Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, 63110
Correspondence
Peng Sun, Department of Radiology,
Washington University School of Medicine,
Campus Box 8225, 4525 Scott Ave, St Louis,
63110 MO, USA. Tel: +1-314-286-2459; Fax:
314-362-0526; E-mail: pengsun@wustl.edu
Funding Information
This study was supported by the National
Institutes of Health (NIH) P01 NS059560.
Received: 13 November 2019; Revised: 24
February 2020; Accepted: 13 March 2020
Annals of Clinical and Translational
Neurology 2020; 7(5): 695–706
doi: 10.1002/acn3.51037
Abstract
Objective: Multiple sclerosis (MS) lesions are heterogeneous with regard to
inflammation, demyelination, axonal injury, and neuronal loss. We previously
developed a diffusion basis spectrum imaging (DBSI) technique to better
address MS lesion heterogeneity. We hypothesized that the profiles of multiple
DBSI metrics can identify lesion-defining patterns. Here we test this hypothesis
by combining a deep learning algorithm using deep neural network (DNN)
with DBSI and other imaging methods. Methods: Thirty-eight MS patients were
scanned with diffusion-weighted imaging, magnetization transfer imaging, and
standard conventional MRI sequences (cMRI). A total of 499 regions of interest
were identified on standard MRI and labeled as persistent black holes (PBH),
persistent gray holes (PGH), acute black holes (ABH), acute gray holes (AGH),
nonblack or gray holes (NBH), and normal appearing white matter (NAWM).
DBSI, diffusion tensor imaging (DTI), and magnetization transfer ratio (MTR)
were applied to the 43,261 imaging voxels extracted from these ROIs. The opti-
mized DNN with 10 fully connected hidden layers was trained using the imag-
ing metrics of the lesion subtypes and NAWM. Results: Concordance,
sensitivity, specificity, and accuracy were determined for the different imaging
methods. DBSI-DNN derived lesion classification achieved 93.4% overall con-
cordance with predetermined lesion types, compared with 80.2% for DTI-DNN
model, 78.3% for MTR-DNN model, and 74.2% for cMRI-DNN model. DBSI-
DNN also produced the highest specificity, sensitivity, and accuracy. Conclu-
sions: DBSI-DNN improves the classification of different MS lesion subtypes,
which could aid clinical decision making. The efficacy and efficiency of DBSI-
DNN shows great promise for clinical applications in automatic MS lesion
detection and classification.
Introduction
Multiple sclerosis (MS) is a common inflammatory cen-
tral nervous system (CNS) disorder that affects over
600,000 people in the United States.1 MS usually begins
with intermittent “attacks” (i.e., relapsing-remitting
course) characterized by transient episodes of CNS dys-
function.2 These clinical attacks, or relapses, are caused by
focal inflammation in the CNS.3 Once the acute inflam-
mation subsides, the acute lesions become chronic, and
may be characterized by varying degrees of demyelination,
axonal injury and loss, gliosis, and residual inflamma-
tion.3
Conventional MRI (cMRI) is often used to characterize
and quantify MS lesions in the CNS,4 with lesion sub-
types being identified and classified based on their inten-
sity using from MR sequences.5 Hypointense areas of
white matter (WM) on T1-weighted imaging (T1WI) are
commonly known as “black holes” (BHs) and “gray
holes” (GHs), depending upon the level of hypointensity.
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BHs and GHs persisting for at least 12 months are mark-
ers of focal tissue injury in MS and are known as “persis-
tent black holes” (PBHs) and “persistent gray holes”
(PGHs).6 Based on histological correlations, PBH are con-
sidered to contain more severe axonal loss compared with
other MS lesion subtypes7. Other MS lesions that are
hyperintense on T2-weighted imaging (T2WI) and lack
hypointensity on T1WI have less severe tissue damage,
and are referred to here as nonblack or gray hole (NBH)
lesions.8,9 While standard cMRI is sensitive in detecting
MS lesions in WM, it requires experience to categorize
the lesion subtype, in addition to longitudinal follow-
up.10
Our laboratory developed a novel diffusion basis spec-
trum imaging (DBSI) method,11,12 and demonstrated its
ability to quantitatively characterize the pathologies that
underlie MRI lesions in a biopsy of a demyelinating brain
lesion and in postmortem MS specimens.13,14 While
DBSI-derived metrics were correlated with axonal injury/
loss, demyelination, and inflammation,11,15 a comprehen-
sive analysis employing DBSI-derived metrics to detect
and differentiate cMRI-based MS lesion subtypes have yet
to be conducted. Herein, we introduce a novel imaging
approach which combines DBSI-derived structural metrics
(as the classifiers) with a deep neural network (DNN)
algorithm. We tested the performance of DBSI-DNN in
detecting and classifying the various MS lesion subtypes,
and compared it to cMRI, as well as DTI and MTR.
Materials and Methods
Subject
The study was approved by the Institutional Review
Board of Washington University School of Medicine.
Thirty-eight people with MS were enrolled after providing
written informed consent. Patient information and details
are included in Table 1.
Image acquisition
Patients were imaged on a 3.0-T Siemens Trio scanner
(Siemens, Erlangen, Germany). T1WI was acquired using
the following parameters: Repetition Time (TR) = 600 ms;
Echo Time (TE) = 9 ms; slice thickness = 2 mm; in-plane
resolution = 1 9 1 mm2; total acquisition time = 4 min.
Magnetization-prepared rapid gradient-echo (MPRAGE)
image with isotropic 1 mm3 resolution was used for identi-
fication of structural landmarks and as a registration target
(TR = 2400 ms, TE = 3.16 ms, TI = 1000 ms, FOV = 256 9
224 mm2). T2WI using fluid-attenuated inversion recovery
sequence was acquired to quantify visible WM lesion volumes
(TR = 7500 ms, TI = 2500 ms, TE = 210 ms, FOV =
256 9 256 mm2, Resolution = 1 9 1 9 1 mm3). Magnetiza-
tion transfer (MT) images were acquired with the following
parameters: TR = 43 ms; TE = 11 ms; Flip Angle = 30
degrees; FOV = 192 9 256 mm2; slice thickness = 3 mm; in-
plane resolution = 1 9 1 mm3; total acquisition time = 8 min.
Magnetization transfer ratio (MTR) maps were calculated pixel-
by-pixel using the equation: MTR = (Soff – Son)/Soff 9 100,
where Son and Soff were signal intensities with and without satu-
ration pulse. Axial diffusion-weighted images (DWI) covering
the whole brain were acquired using a multi-b value diffusion
weighting scheme (99 directions, maximum b-value 1500 s/
mm2) and the following parameters: TR = 10,000 ms;
TE = 120 ms; FOV = 256 9 256 mm2; slice thick-
ness = 2 mm; in-plane resolution = 2 9 2 mm2; total acquisi-
tion time = 15 min. Eddy current and motion artifacts of DWI
were corrected before susceptibility-induced off-resonance field
was estimated and corrected.16
MS lesion identification
Lesions were classified as being black hole, gray hole, or
nonblack or gray hole using an objective and semiquanti-
tative intensity ratio (IR) method developed in our previ-
ous work9. This method uses a protocol that allows a
single investigator to reliably determine lesion types. The
range of IR used for black hole, gray hole, and nonblack
or gray hole were 1.00 to 1.70, 1.71 to 2.60, and > 2.60,
respectively 9. PBHs (Fig. 1A) and PGHs (Fig. 1B) were
defined as being present for at least 12 months, and not
in the setting of contrast enhancement. Acute black hole
(ABH) and acute gray hole (AGH) were hypointensities
on T1WI within currently contrast enhancing lesions
(Fig. 1C). ABHs were not included in this study because
the number of ABHs identified was insufficient for model
Table 1. Patient and lesion characteristics.
Patient/lesion characteristics No.
Patient 38
Age (years), median (range) 55 (25–72)
Disease duration (years), median (range) 13.7 (1.5–43.3)
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training. Nonblack or gray hole (NBH, Fig 1D) lesions
were hyperintense on T2WI images without hypointensity
on T1WI, and had IR> 2.60. NAWM ROIs were delin-
eated from the contralateral side of the brain to the
lesions, in areas with no lesions or “dirty-appearing”
white matter on T2WI imaging (Fig. 1E). NAWM ROI
volumes were purposely made comparable to lesion vol-
umes to avoid class imbalances.
All the lesions in this manuscript were classified by the
IR method, used by a neurologist with> 20 years of clini-
cal experience prior to being analyzed in this study.
Amira 6.0.1 visualization and analysis software (FEI,
Hillsboro, OR) was used to quantify intensity for each
hypointense lesion on all scans. Note that the lesion
intensity assessment requires establishing the baseline
intensity of each scan to account for scan-to-scan inten-
sity variations.
Diffusion basis spectrum imaging
DBSI models the diffusion-weighted MRI signals as a lin-
ear combination of multiple tensors describing both the
discrete anisotropic content (axonal fibers) and an isotro-
pic diffusion spectrum component encompassing the full
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 are the normalized signal and b-value
of the kth diffusion gradient, NAniso is the number of ani-
sotropic tensors, wik is the angle between the k
th diffusion
gradient and the principal direction of the ith anisotropic
tensor, kki and k?i are the axial diffusivity (AD) and
radial diffusivity (RD) of the ith anisotropic tensor, fi is
the signal intensity fraction for the ith anisotropic tensor,
and a and b are the low and high diffusivity limits for the
isotropic diffusion spectrum f(D). The anisotropic diffu-
sion component describes water molecules inside and
outside myelinated or nonmyelinated axons. DBSI-derived
anisotropic signal fractions (fi, i.e., fiber fraction) reflects
the apparent axonal density in WM. DBSI-derived AD
and RD retain the pathological specificity for axon and
myelin integrity as in previously published models,17,18
without confounds from non–fiber related changes. The
DBSI-derived “restricted” isotropic diffusion fraction
(ADC ≤ 0.3 µm2/ms) has been shown to reflect cellular-
ity.12 Hindered (0.3 µm2/ms ≤ ADC ≤3 µm2/ms) and free
(ADC ≥ 3 µm2/ms) isotropic diffusion components rep-
resent water molecules in less densely packed
environments, such as areas of tissue disintegration or
edema, or contaminating cerebrospinal fluid (CSF).12,19,20
Image processing
Whole-brain voxel-wise DTI and DBSI analyses were per-
formed by an in-house software developed using
MATLAB (MathWorks). To control for scan-to-scan
variation within individual scans, cerebrospinal fluid
(CSF), which is unaffected by MS pathologies, was used
as the baseline for individual scans and to assess signal
intensities of MS lesions on T1WI and T2WI. Regions of
CSF (≥ 100 voxels) were defined on axial slices where the
anterior horns of the lateral ventricles were widest. Voxels
containing choroid plexus or within two voxel distance
from the ventricle edge were excluded. For each voxel in
MS lesions, the voxel intensity was divided by the CSF
intensity to normalize b0, T1WI, and T2WI intensities.
DNN model development and optimization
Our complete dataset consisted of 43,261 imaging vox-
els from 499 MS lesions obtained from 38 patients.
The collected voxels were split into training, validation,
and test datasets with a ratio of 8:1:1, respectively.
Imaging voxels from test datasets were separated from
lesions that were used in the training and validation
steps. Validation set was employed to fine tune the
model hyper-parameters. We then compared four differ-
ent DNN models that incorporate different MRI met-
rics. The first DNN model (DBSI-DNN) incorporated
both DBSI metrics and normalized T1WI and T2WI
intensities. The second model (DTI-DNN) used DTI
metrics in conjunction with normalized T1WI and
T2WI intensities. The third model (MTR-DNN) used
MTR metric in combination with normalized T1WI
and T2WI intensities. The fourth DNN model used
normalized T1WI and T2WI intensities from cMRI
alone. The diffusion metrics assessed with our DNN
modeling included eight diffusion metrics provided
from DBSI and another four from DTI (Fig. 2). Specifi-
cally, DBSI metrics include, fiber fraction, fiber frac-
tional anisotropy (FA), fiber AD, fiber RD, restricted
isotropic diffusion fraction (restricted fraction), hin-
dered isotropic diffusion fraction (hindered fraction),
free isotropic diffusion fraction (water fraction) and
normalized b0 intensity. DTI metrics include ADC, FA,
AD, and RD.
The DNN model was developed using Tensorflow
frameworks in Python.21 In general, the DNN models
were constructed with multiple fully connected neural
network. Exponential linear units (ELU) were used to
activate specific functions in each hidden layer. Batch
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Figure 1. Different MS lesion subtypes. Columns from left through right are representative cases of persistent black hole (PBH) lesion (A),
persistent gray hole (PGH) lesion (B), acute gray hole (AGH) lesion (C), nonblack or gray hole (NBH) lesion (D), and normal appearing white matter
(NAWM) region (E). Red arrows indicated the location of MS lesions.
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Figure 2. Distribution histograms of different MRI metrics for different MS lesion types. Imaging voxels from persistent black holes (PBH, dark
blue), persistent gray holes (PGH, red), acute gray holes (AGH, green), nonblack or gray hole lesions (NBH, cyan), and normal appearing white
matter (NAWM, purple) were plotted to show the distributions for cMRI, MTR, DTI, and DBSI metrics. X-axis = metric intensities; Y-
axis = frequency; ADC = apparent diffusion coefficient; FA = fractional anisotropy; AD = axial diffusivity; RD = radial diffusivity.
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normalization was performed with a mini-batch size of
200 before feeding data to the next hidden layer to
improve model optimization and to prevent overfitting.
The final layer was a fully connected softmax layer that
produces a likelihood distribution over the five output
classes. DNN models with varying numbers of hidden lay-
ers, nodes and training epochs were tested for model
optimization. The network was trained with random
initialization of the weights as described.22 The Adam
optimizer was used with the default parameters of
b1 = 0.9 and b2 = 0.999 and a mini-batch size of 200.
The cross-entropy loss function was chosen, and the
model was trained to minimize the error rate on the
development dataset. Generally, the hyper-parameters of
the network architecture and optimization algorithm were
chosen through a combination of grid search and manual
tuning.
Statistical analysis
Confusion matrices were calculated and used to illustrate
the specific examples of MS lesion classes where the
DNN prediction contradicts the neurologist’s diagnoses.
The one-versus-rest strategy was implemented to perform
ROC analysis; and area under curve (AUC) was calcu-
lated to assess model discrimination of each lesion type.
Sensitivity and specificity values were calculated at the
optimal cut off points. The precision–recall curve was
calculated to demonstrate the relationship between preci-
sion and recall, which provides complementary informa-
tion to the ROC curve since the dataset included
imbalanced classes. To address the imbalanced class data,
we also calculated F1-score, a measure of accuracy that
considers both the precision and the recall of the test, for
each model. The best F1-score is 1, indicating perfect pre-
cision and recall, and the worst is 0. All the 95% confi-
dence interval values were calculated with bootstrapping
methods iterated 1000 times.23
Results
MS patient and lesion characteristics
A total of 38 patients, 12 males and 26 females, were
recruited for this study. The patients averaged 55 years
old ( 10.6 years). Among these patients, 15 had primary
progressive MS, 10 had secondary progressive MS, and 13
had relapsing remitting MS (Table 1). Total 92 PBH
lesions, 89 PGH lesions, 16 AGH lesions, 189 NBH
lesions, and 113 NAWM regions were identified, with
average volumes of 108.3, 66.5, 141.1, 60.6, and 120.9
mm3, respectively. Three of the 38 subjects had no PBH
or PGH lesions.
Histogram analysis of different MRI metrics
Distribution profiles were created using metrics derived
from cMRI, DTI, DBSI, and MTR for the different MS
lesion types (Fig. 2). Overall, the five lesion subtypes
showed a similar hierarchical pattern regardless of the
imaging metric used. Upon visual examination of the dis-
tributions, most of the imaging metrics showed a contain
level of distribution differences, but no individual metrics
was sufficient to discriminate lesions types using regular
statistical comparisons. DNN was the better choice to rec-
ognize the patterns of such complexity in lesions.
DNN model optimization and validation
The optimization of DNN models were assessed by com-
paring overall validation accuracies of all four models.
DNN with none to 11 hidden layers have smaller stan-
dard deviations than DNN with more or fewer hidden
layers, indicating a better reliability (Fig. 3A). Further,
optimal number of training epochs and nodes in each
hidden layer were tested. DNN with 100 to 200 nodes per
hidden layer was optimal, which required less than 100
training epochs to achieve 90% validation accuracy
(Fig. 3B). DNN with fewer nodes per hidden layer needed
an increasing number of epochs to attain 90% validation
accuracy in an exponential fashion. In summary, we
demonstrated that the optimal DNN structure of 10 hid-
den layers and 100 nodes per layer could achieve over
90% accuracy and minimal standard deviation within 100
training epochs (Fig. 3C).
Performance and comparisons of the four
DNN models
For one independent test dataset (n = 4326), DBSI-DNN
model achieved an overall concordance with neurologist
determinations of all five MS lesion subtypes with a total
error rate of 6.6%, which is significantly lower than DTI-
DNN model (error rate: 19.8%), MTR-DNN model (error
rate: 21.7%), or the cMRI-DNN model (error rate:
25.8%). We used confusion matrices to indicate the dis-
cordances between model predictions and neurologist-de-
termined lesion/region types derived from each model
(Fig. 4). DBSI-DNN discriminated PBH, PGH, AGH,
NBH, and NAWM with positive prediction rates of
91.3%, 83.4%, 90.1%, 92.3%, and 97.9%, respectively,
outperforming the other three models.
DTI-DNN had a next-best performance in discriminat-
ing PBH, NBH, and NAWM with rates of 80.1%, 84.8%,
and 95.8%, respectively. DTI-DNN performed worse in
discriminating PGH and AGH with a 45.7% and 48.1%
discrimination rates, respectively. MTR-DNN model
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distinguished NAWM well with a 94% rate. PGH dis-
crimination was only 63.3% accurate using the MTR-
DNN model. cMRI-DNN model discriminated NBH
(82.3% true positive rate) and NAWM (96.1% true posi-
tive) lesions. However, this model did not perform well
on other lesion types. Specifically, PGH (35.2% true posi-
tive rate) were often incorrectly predicted to be PBH
(24.4%) or NBH (37.8%) lesions. The true prediction rate
of AGH was thus 3.2% with cMRI-DNN model.
The one-versus-rest classification strategy was used to
calculate ROC and precision–recall curves to compare the
performances of each DNN model for discerning the
specific lesion/tissue type. For each model, ROC (Fig. 5A)
and precision–recall (Fig. 5B) curves for the five cMRI-
defined tissue types were plotted together for comparison.
DBSI-DNN demonstrated the best performance on both
ROC and precision–recall analyses, with higher ROC
AUC and precision–recall AUC values than any other
model. DTI-DNN, MTR-DNN, and cMRI-DNN ROC
displayed AUC values higher than 0.860 (Fig. 5A), how-
ever, ROC analysis is insensitive to class imbalance, and
could overestimate model performance. Precision–recall
curves would, therefore, provide complement information
to ROC. The precision–recall analyses indicated CTI-
DNN, MTR-DNN, and cMRI DNN to perform worse
than DBSI-DNN (Fig. 5B). For example, the precision–re-
call AUC values for PGH and AGH in the non-DBSI-
DNN models were all lower than 0.650 (Fig. 5B). We
used bootstrap method with 1000 iterations to calculate
ROC AUC, sensitivity, and specificity values for DBSI-
DNN model (summarized in Table 2).
We found that DBSI-DNN performed the best out of
the four models, with a PBH F1-score of 0.923, a PGH
F1-score of 0.823, and an AGH F1-score of 0.887
(Table 2). DBSI-DNN indicated much higher F1-scores
for all the MS lesions subtypes than DTI-DNN model,
MTR-DNN model, and cMRI-DNN model (Table S1).
Discussion
MRI has played a vital role in the diagnosis and manage-
ment of MS for decades.24 However, conventional T1WI
and T2WI brain imaging techniques do not correlate well
with MS pathologies because of the complex pathologic
heterogeneity of MS lesions.25,26 Also, conventional T1WI
and T2WI imaging contrasts vary from scan to scan and
are not quantitative, as they depend not only on the MR
characteristics of brain tissue but also the scanner ven-
dors, magnet strength, and pulse sequences.
Our goal is to develop a means to noninvasively evalu-
ate the underlying pathology in living people with MS
and other CNS disorders. We previously developed DBSI
demonstrating its ability to quantitatively characterize
CNS pathologies in postmortem MS specimens and in
preclinical MS models.11-14 Here, we hypothesized that
DBSI-DNN would be able to distinguish various MS
lesion types.
To test our hypothesis, we compared DBSI, DTI, MTR,
and conventional MRI, each in combination with opti-
mized DNN model, in their classification accuracies on
the four common MS lesion subtypes and NAWM. We
found that using DBSI, T1WI, and T2WI as DNN inputs
Figure 3. Comparison of DBSI-DNN model with varying number of hidden layers and node count. (A) Neural nets with 1 to 20 hidden layers
were tested on 70 different random states of our data for validation accuracy. About 80% of the data was used to train the DNN, 10% was
used for testing and another 10% for validating. Reliability/predictability of neural networks are modelled by standard deviation. All hidden layers
tested contain 100 nodes. (B) The number of epochs required for neural networks to reach 90% validation accuracy are shown. Neural networks
with 10 to 200 nodes in each hidden layer were tested. All neural networks contain 10 hidden layers. Each neural network was tested via 10-fold
cross validation tests 10 times. Neural networks with 10 and 20 nodes did not attain a validation accuracy of 90% in any of its trials within 150
epochs, and therefore are not shown in the figure. (C) The optimized neural network of 10 hidden layers each containing 100 nodes was tested
on 70 different random states of our data for validation accuracy. This graph shows the validation accuracies over these trials.
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Figure 4. Results on lesion subtypes predictions from four different models. (A) Total error rate (1 – accuracy) on the lesion predictions from the
four different models. Values outside the light blue area (5.9%–7.3%) are significantly different (95% confidence interval, using a two-sided
exact binomial test) from the DBSI-DNN performance. (B) Confusion matrices for the predictions of the DNN models versus lesion identification
using the intensity ratio method applied by an experienced neurologist (“gold standard”). Rows contain lesion classifications identified using the
intensity ratio method (PBH – persistent black hole; PGH – persistent gray hole; AGH – acute gray hole; NBH – nonblack or gray hole lesion;
NAWM – normal appearing white matter). Columns contain lesion classifications as predicted by different DNN models, which includes DBSI-DNN,
the DTI-DNN model, the MTR-DNN model and the cMRI-DNN model.
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produced the most accurate classification results. Confu-
sion matrices indicated that models trained on DBSI met-
rics had higher positive prediction rates, and the ROC
and precision–recall curves showed that the DBSI-DNN
model had greater overall classification accuracy for each
of the lesion type than DNN models based on other three
commonly used imaging methods.
DBSI outperformed DTI, a widely applied imaging
method for imaging CNS disorders.27-29 DTI’s prevalence
can be attributed to its metrics’ ability to correlate with
axonal injury and demyelination,17,30,31 however, this sin-
gle tensor Gaussian diffusion model is inadequate for
resolving coexisting complicated pathologies.32 DBSI
adopts a novel data-driven model that models and
quantifies isotropic and anisotropic diffusion tensors
within imaging voxels.12,20,33 Based on immunohisto-
chemical data from a murine MS model and human CNS
tissue specimens, restricted and nonrestricted isotropic
diffusion reflects inflammatory components as well as
intrinsic cells and extra-cellular space, whereas anisotropic
diffusion reflects axonal fibers.14,34 DBSI-derived metrics
reflected specific components of MS CNS pathology, such
as demyelination, edema, and increased cellularity.13,14
DBSI outperforms conventional DTI in detecting complex
MS pathologies.
MS lesion burden has often been reported as the sum
of lesion volumes, but the degree of tissue destruction
may vary among lesions.35 A prior comparison of imaging
Figure 5. ROC and precision–recall curves. (A) ROC curves calculated on an independent test set (n = 4327) of four different models (DBSI, DTI,
MTR, and cMRI). (B) Precision–recall curves calculated for DBSI, DTI, MTR, and cMRI models. DBSI showed the greatest performances on both
ROC and precision–recall curves for all the five different lesions compared with other models. Class labels are as follows: Cyan, PBH. Red, PGH.
Purple, AGH. Blue, NBH. Black, NAWM.









PBH 0.991 (0.989–0.994) 95.9 (93.9–97.4) 95.0 (93.7–96.SS8) 0.923
PGH 0.977 (0.971–0.982) 92.9 (90.1–95.9) 93.4 (90.1–95.3) 0.823
AGH 0.987 (0.980–0.992) 95.1 (91.3–98.6) 95.0 (91.1–97.6) 0.887
NBH 0.981 (0.977–0.985) 93.5 (91.7–95.6) 93.1 (91.2–94.6) 0.918
NAWM 0.998 (0.997–0.998) 99.1 (97.9–99.8) 97.3 (96.3–98.4) 0.973
The 95% confidence interval values were calculated using bootstrap with 1000 iterations.
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and neuropathology in over 100 MS lesions reported
the degree of hypointensity to strongly associate with
axonal density.36 In comparison to other MS lesion
types, the pathologic correlation of PBH lesions con-
tains more axon loss and extracellular matrix destruc-
tion.37-39 Counts and volume of PBHs positively
correlated with neurological disability.40,41 Compared to
PBHs, PGHs reflect a lower degree of axonal loss. In
contrast to PBH and PGH lesions, the “black” and
“gray” areas of ABH and AGH lesions are more likely
caused by inflammation and edema, since most ABH/
AGH lesions will resolve to become isointense on
T1WI within months of contrast resolution.27 Here we
showed that DBSI metrics combined with DNN enabled
accurate classification of MS lesions, which is important
because different MS lesion types are associated with
different clinical outcomes. A quantitative method to
distinguish each MS lesion type could improve patient
monitoring and potentially be useful to measure out-
come in clinical trials.36
The relatively small number of subjects (n = 38) and
the naturally heterogeneous MS lesions of our data lim-
ited the general implications of this study. However, we
performed DNN analyses on 499 MS lesions, containing a
total of 43,261 imaging voxels. We performed a voxel-
based computation to derive DBSI metrics, which avoids
the issues concerning heterogeneity of MS lesions. The
data distribution was unbalanced among different lesion
and region types. Although this could compromise the
performance of a DNN model, we employed precision–re-
call curves to provide complement ROC analyses. This
study was based on data from a single institution using
the same scanner. In the future, we will examine classifi-
cation models across different scanner platforms and
acquisition parameter variations.
Conclusions
A DNN analysis based on DBSI (“DBSI-DNN”) provided
a 93.4% prediction accuracy in classifying MS lesions sub-
types. This model outperformed DTI-based or MTR-
based DNN models. DBSI-DNN demonstrates great pro-
mise as a marker of lesion subtype, which is an indicator
of lesion severity, particularly in relationship to axonal
loss. Future additional longitudinal studies with larger
cohorts, different scanners, and multiple centers are
imperative to explore the possibilities of applying DBSI-
DNN on a broader scope.
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Supporting Information
Additional supporting information may be found online
in the Supporting Information section at the end of the
article.
Table S1. Diagnostic performances of DTI-DNN, MTR-
DNN and cMRI-DNN models.
Figure S1. Illustration of deep neural network. PBH, per-
sistent black hole; PGH, persistent gray hole; ABH, accute
gray hole; NBH, non-back or gray hole; NAWM, normal
appearing white matter.
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